The Western blotting results suggest that DHM possesses the potential to augment T2DM and associated kidney injury in db/db mice by upregulating the PI3K/AKT signaling pathway while concurrently downregulating the MAPK signaling pathway. Here, AKT1 is linked to type 2 diabetes mellitus.